Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta.

× No keyword cloud information.

17 in total

1. Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines.

Authors: G Bepler; A Koehler; P Kiefer; K Havemann; K Beisenherz; G Jaques; C Gropp; M Haeder
Journal: Differentiation Date: 1988 Impact factor: 3.880

2. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.

Authors: H H Heidtmann; M Hofmann; E Jacob; C Erbil; K Havemann; R Schwartz-Albiez
Journal: Cancer Res Date: 1989-12-15 Impact factor: 12.701

3. Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752).

Authors: J Bergh; K Nilsson; L Zech; B Giovanella
Journal: Anticancer Res Date: 1981 Impact factor: 2.480

4. Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester.

Authors: U Salge; P Kilian; K Neumann; H P Elsässer; K Havemann; H H Heidtmann
Journal: Int J Cancer Date: 1990-06-15 Impact factor: 7.396

5. Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.

Authors: L R Lund; A Riccio; P A Andreasen; L S Nielsen; P Kristensen; M Laiho; O Saksela; F Blasi; K Danø
Journal: EMBO J Date: 1987-05 Impact factor: 11.598

Review 6. Some recent advances in the chemistry and biology of transforming growth factor-beta.

Authors: M B Sporn; A B Roberts; L M Wakefield; B de Crombrugghe
Journal: J Cell Biol Date: 1987-09 Impact factor: 10.539

7. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.

Authors: E F Plow; D E Freaney; J Plescia; L A Miles
Journal: J Cell Biol Date: 1986-12 Impact factor: 10.539

8. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.

Authors: J F Cajot; W D Schleuning; R L Medcalf; J Bamat; J Testuz; L Liebermann; B Sordat
Journal: J Cell Biol Date: 1989-08 Impact factor: 10.539

Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta.

1. Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines.

2. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.

3. Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752).

4. Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester.

5. Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.

Review 6. Some recent advances in the chemistry and biology of transforming growth factor-beta.

7. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.

8. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.

9. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

10. A study of proteases and protease-inhibitor complexes in biological fluids.

1. Crosstalk of AP4 and TGFβ receptor signaling in NSCLC.

2. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

3. Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression.